An erythrocyte membrane coated mimetic nano-platform for chemo-phototherapy and multimodal imaging.
Feng XiaoJialong FanChunyi TongChang XiaoZhou WangBin LiuMuhammad DaniyalWei WangPublished in: RSC advances (2019)
The tumor variability and low efficiency associated with conventional chemical drugs provide an impetus to develop drug-carrying systems with targeted accumulation and controllable release behavior. Herein, DOX-loaded Prussian blue (PB) nano-composites are developed after coating with erythrocyte membrane (EM) and modifying with folic acid (FA). In these nano-composites, PB nanoparticles mixture with different shapes were adopted to improve the photothermal performance, which is highly helpful for cancer photothermal ablation and controllable drug release. In addition, the nano-composites were endowed with high biocompatibility, immune evading capacity, pH-/photo-responsive release behavior, and markedly prolonged blood circulation time, which was reflected by a 99.6% cervical tumor growth inhibition value (TGI) in vivo . Meanwhile, they functioned as multimodal bioimaging agents for photothermal, fluorescence, and photoacoustic imaging of tumors. The reported strategy can be applied for personalized therapy of various tumors by modifying the tumor-targeting molecule on the surface of nanoparticles.
Keyphrases
- cancer therapy
- drug release
- drug delivery
- photodynamic therapy
- aqueous solution
- high resolution
- reduced graphene oxide
- heavy metals
- fluorescence imaging
- pain management
- squamous cell carcinoma
- quantum dots
- risk assessment
- papillary thyroid
- drug induced
- mass spectrometry
- childhood cancer
- radiofrequency ablation
- living cells
- walled carbon nanotubes
- single molecule
- tissue engineering
- rectal cancer